Back to Atlas
APotentially durableStandard research/education caution
CMP-0098
Research tool
Nutlin-3a
Senolytic / p53-MDM2
Context-dependent senolytic and cancer research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- MDM2 inhibition stabilizes p53 and can induce senescent-cell apoptosis
- Primary market use
- Senolytic / oncology research
Pharmacology
- Molecular weight (Da)
- 581.5
- Oral bioavailability
- Oral human data not established
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Research tool
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Useful mechanistic tool; not clinically practical as a wellness compound